Literature DB >> 26622134

Corneal cross-linking treatment of keratoconus.

Mahgol Farjadnia1, Mohammad Naderan1.   

Abstract

Keratoconus as the most common cause of ectasia is one of the leading cause of corneal transplants worldwide. The current available therapies do not modify the underlying pathogenesis of the disease, and none of the available approaches but corneal transplant hinder the ongoing ectasia. Several studies document Crosslink defect between collagen fibrils in the pathogenesis of keratoconus. Collagen cross link is a relatively new approach that with the application of the riboflavin and ultraviolet A, new covalent bands reform. Subjective and objective results following this method seem to be promising. Endothelial damage besides other deep structural injury, which is the major concern of this technique have not yet been reported, when applying the standard method.

Entities:  

Keywords:  Corneal cross linking; keratoconus; ultraviolet A

Year:  2015        PMID: 26622134      PMCID: PMC4640047          DOI: 10.4103/0974-620X.159105

Source DB:  PubMed          Journal:  Oman J Ophthalmol        ISSN: 0974-620X


Introduction

Keratoconus is a progressive noninflammatory disease of the cornea, affects both eyes once in its progression. It usually begins sometime in puberty and its advance is predictably arrests in the third or fourth decade.[1] Estimated incidence in a different society ranges from 5 to 20 in 10,000 persons, and a prevalence of 54 in 100,000 is reported in different studies.[23] With this prevalence, keratoconus is regarded as the most common corneal ectasia.[4] This thanks to advances in diagnosing modalities, the reported incidence in recent studies seems to be even higher. Females seem to be more affected. And no ethnicity is spare from this disease.[456]

Method of Literature Review

We searched the National Library of Medicine's PubMed database and Elsevier Scopus database with a subsequent review of the accompanying references. The major search words and word combinations included: Corneal cross linking treatment of keratoconus; corneal cross linking, treatment options of keratoconus, perspective of keratoconus, cross linking and ultraviolet A (UVA), complications of corneal cross linking, outcome of corneal cross linking, methods and techniques of corneal cross linking, corneal cross linking risks. In addition, the citations from the above searches were also included. Cases from the nonEnglish literature were not included. All identified documents were examined, and those that were relevant were retrieved for inclusion in the review.

Pathogenesis

The exact underlying pathogenesis of the keratoconus despite recent researches remains unknown. Nevertheless, different hypotheses have been proposed. It seems that offending assaults such as trauma, ultraviolet (UV) or atopy fire an inflammatory cascade in susceptible patients that leads to degeneration of the corneal stroma.[7] It has been found that interleukin 1 receptors are presented 4 times more on the surface of keratinocytes of keratoconic patient. This cytokine is postulated to induce apoptosis in keratinocytes and regulates keratinocyte proliferation and differentiation.[89] Moreover, a role in modulating the expression of metalloproteinase has been suggested for this cytokine.[9] Imbalances between other proinflammatory agents and anti-inflammatory agents have also been found. Cellular adhesion molecule-1, vascular cell adhesion molecule-1 and interleukin 6 are even expressed as much as 40 times, whereas expressions of anti-inflammatory agents like interleukin 10 are markedly reduced.[10] Disparities between proteinase and proteinase inhibitor activity have also been postulated.[11] The discovered disproportion can lead to the corneal stromal degradation; as the core pathological finding in keratoconus. Sawaguchi et al. found that α2-macroglobulin and α1-antiprotease levels as a proteinase inhibitors are significantly less in keratotic eyes than normal eyes[12] and studies demonstrate a higher activity for lysosomal and catabolic enzymes like the proteinase.[13] Collagen alignment and components are also of significant importance. More than two third of the dry weight of the cornea is composed of collagen.[14] To build up the transparency of the cornea the axis and three-dimensional structure of collagen fibrils should be arranged elaborately. Researchers found differences in certain collagen types between normal and keratoconic eyes and retard in the wound healing process could be attributed to these differences.[15] There are also reports that demonstrate higher prevalence of keratoconus in patients with a known connective tissue disease such as osteogenesis imperfecta and Ehlers–Danlos.[1617] Researchers also found that severe mitral valve prolapse pending finally to surgery occurs more commonly in these people.[18] Findings that make a genetic abnormality in connective tissue, especially collagen genes are even more possible. Collagen cross linking is defective in type VI Ehlers–Danlos due to lysyl hydroxylase deficiency. This type is the most common reported form that has a correlation with keratoconus[1920] and paucity of these cross links seems to be one of the basis of corneal laxity at least in some patients.

Histopathological Findings

Based on the severity of the disease, microscopic changes happen in each layer of the cornea. The epithelium of the basement membrane disrupts and breaks appear in Bowman's membrane. Posterior proliferation of epithelium to Bowman's membrane creates Z shape deformities that become filled with periodic acid–Schiff positive materials. As the disease progresses, Iron deposits appear within and between epithelial cells and degenerating fibroblasts and keratinocytes appear in the stroma. Arrangement of stromal fibrils gets distorted as well. Descemet's membrane and endothelium usually do not undergo noteworthy changes. Nevertheless, breaks in Descemet's membrane and increased cellular pleomorphism in endothelial cells have been reported.[21]

Clinical Manifestation

Clinical findings depend on the stage of the disease and are a spectrum from being completely asymptomatic to severely distorted vision. Fortunately, keratoconus barley ends to complete blindness. At initial steps, there are no symptoms and the disease goes unnoticed by the patient and physician, unless a diagnostic procedure like keratography is done. Gradually the disease distorts the vision so severely that the refractive errors cannot be compensated with spectacles. Amsler classified the subclinical form as fruste form and defined it as four or less degree downward deflection from the horizontal axis with handheld keratosope.[2223]

On clinical examination with a slit lamp following findings might be visible

After dilating the pupil, scissoring of the retinoscopic is visible. Conical protrusion, as it comes from the name of the disease, is a frequent finding in the incipient phase. Stromal thinning is very often found commonly inferiorly or inferotemporally. Vogt's striae are fine upright lines paralleling the axis of the cone deep in stroma and Descemet's membrane. Fleischer's ring defined as iron deposition around the cornea. Munson's sign; V shape conformation of the lower lid when gazing downward and Rizzuti's sign; well demarcated beam of light just around the nasal limbus, exhibited by lateral illumination of the cornea. These two latter signs are useful external signs especially in advanced keratoconus. Other additional signs like stromal scars and visible corneal nerves might be found too.[212223]

Classification

Based on disease evolution, Amsler categorized the disease from fruster or subclinical to severe [Table 1].[42425]
Table 1

The Amsler–Krumeich classification of keratoconus severity[24]

The Amsler–Krumeich classification of keratoconus severity[24] Morphologically the disease is classified as: Nipple with conical diameter <5 mm and round in morphology. This type is easily corrected with contact lenses.

Oval

The cone has a diameter more than 5 mm commonly in the inferotemporal corneal quadrant and is peripherally located. This form is not easily corrected with contact lenses. In keratoglobus, more than 75% of the corneal surface is cone like. Contact lens in visual correction has been almost always disappointing.[26]

Management

Contact lenses are the first choice of therapy for more than 90% of patients. In the early phase of the disease, soft lenses seem to be adequate but with further progression rigid gas permeable lenses are more functional. In very early phase spectacles can also be applied. However, the abnormal shape of the cornea does not let for proper matching with spectacles. In patients with severe keratoconus and those who do not tolerate the contact lens, surgery is the next step. There are different methods of surgeries while penetrating keratoplasty (PKP), in which the full thickness of the cornea is removed enjoys from the most popularity. According deep lamellar keratoplasty, in which the surgeon leaves the descemet's membrane and endothelium intact, less rate of graft rejection is reported. Nevertheless, PKP seems to bestow a better visual acuity. Photorefractive keratectomy, Intra-corneal ring segment and implantation of intraocular lens are other surgical maneuvers that are applied solely or in combination with other techniques.[232728]

Corneal Cross Linking

Although cross linking was a common method in different industries including chemistry to build up polymers, medical engineering for heart prostheses and dentistry for certain material,[29] entrance of this method to ophthalmology comes back to 1997, when Spörl et al. induced cross link in corneal collagens.[30] Collagen cross link created a hopeful prospective for corneal ectasia of all kinds and especially keratoconus. Before that there was no treatment to modify the underlying pathophysiology and arrest further ectasia. Collagen is one of the core structural proteins in the body. Its three-dimensional structure gives especial features to this protein. With minor changes in the structure of this super molecule, the elasticity, tensile rigidity, and resistance capacity differs significantly. Each molecule of collagen is made of three left-handed α-helix chains. Each chain is a repeat of three amino acids: Pro-X-Gly or Hypro-X-Gly. Glycine is a small amino acid that its presence is of paramount importance of forming strong bonds between α-helices. Substitution of this aa with another amino acids lead to severe connective tissue disorders. Collagen fibrils are linked to gather in a network pattern. Lysyl hydroxylase is the key enzyme for creating covalent bonds between collagen fibrils.[14] And as it was already mentioned this enzyme is defective in certain types of Ehlers–Danlos syndrome and keratoconus is more prevalent in this group. Other researchers have also shown that less covalent cross linkage is associated with decreased mechanical strength.[31] Nevertheless, Cannon and Foster declared that natural paucity in cross linkages does not substantially lead to keratoconus.[32] As the age increases, more covalent bonds form between collagen fibrils, also called the tropocollagen, in all parts of the body including the cornea.[3334] This cross linkage increases Young's modulus.[35] Finding that might explain the arrest in the progression of keratoconus after the fourth decade.[36] Three-dimensional images of normal corneal stromal collagen, which were taken using femtosecond high energy laser to induce signals in a process named second harmonic generation, demonstrated highly interwoven network in the anterior part of the cornea; “sutural lamella” that insert to Bowman layer. This highly organized “sutural lamella” does not appear in keratoconic eyes.[37]

Mechanism

Increase in collagen cross links to arrest the conical progression has been a reasonably appealing strategy. In 1998, Spoerl applied Glutaraldehyde and Karnovsky solution to induce collagen cross links in vivo. This technique was efficient. Yet the toxicity, deep penetration of the substance and consequent scar formation makes the in vivo application restricted.[30] Wollensak et al. were the first group who innovated riboflavin and UV for creating collagen crosslinks.[35] The collagen cross-link is a photo-induced reaction. Riboflavin (Vitamin B2) functions as a photosynthesizer that becomes excited with UVA at 370 microns and goes to higher levels of energy. The resultant is oxidizing substance and free radicals cause formation of new covalent bonds between collagen fibrils.[3839]

Technique

Despite trivial differences in detail, most researchers use the instruction first described by Dresden: After mechanical debridement of 7–9 mm of corneal epithelium under local anesthesia chemical debridement with alcohol similar to debridement technique used in LASIK laser in situ keratomileusis can also be applied. Riboflavin 0.1% solution is used every 2–3 min for 30 min. After this time fluorescence appears while examining the eye with a slit lamp. Then UVA radiation starts. Before radiation, ultrasonic pachymetry is necessary to confirm that thinnest part of the stroma is not <400 microns. This least diameter has been shown in the literature to keep the posterior structures protected from UVA radiation. The wavelength of UVA is arranged at 370 nm. UVA is mostly absorbed by riboflavin in this wavelength. Using the procedure, the stroma is always saturated with riboflavin. After the surgery antibiotic and corticosteroids, both topically are used, and a bandage contact lens is inserted. This contact lens will be removed in the 3rd day.[40]

Postsurgical Outcomes

Biomechanical changes

After the cross linking, cornea shows more resistance against the enzymatic degeneration and its stress-strain measurement increase.[3541] Diameter of collagen fibrils is also reported to be increased.[42] Clinical studies demonstrate significant improvement and all published publications reported arrest in corneal ectasia.[43] In the first case series that was done by Wollensak et al. on 23 patients, a significant decrease in the topographic index (K max) by 2.01 D and spherical equivalent (SE) by 1.14 D was observed. Best corrected visual acuity (BCVA) was improved by 1.26 as well.[44] Further studies in other countries showed similar findings in K max, BCVA, and spherical equivalent.[45464748495051] Improvement in visual acuity seems to be due to astigmatism correction,[454647] which is not necessarily accompanied by better keratometric indices. Modification in corneal anterior surface deformity and astigmatism correction lead to improvement in higher order aberrations especially coma aberration. With all very promising results, reverse in the presence ectatic cornea is subtle.

Possible Complications and Risk

Corneal edema happens very often post surgically and is usually a self-limited consequence.[52] Corneal persistent haziness is also observed in the anterior two third of the cornea that is the result of a lacunar honey comb-like hydration pattern, which is visible under confocal microscope and is a positive indication of sufficient cross linking. This phenomenon does not seem to distort the vision significantly.[5354] Epithelial damage, corticosteroid use and contact lens bandage after the procedure render the cornea to infection.[55] Escherichia coli, Staphylococcus epidermis, poly microbial infections with Streptococcus salivarius, Streptococcus oralis, and coagulase negative staphylococcus specimens have been the offending agents in different studies.[565758] Severe keratitis caused by Acanthamoeba and Pseudomonas have been reported.[5960] Primary herpetic keratitides with geographical ulcer and iritis,[61] as well as recurrence of herpetic keratitis, is also reported.[6162] Coskunseven et al. found a subtle increase in intraocular pressure by 2 mmHg.[435152] Ensuing stiffness of the cornea after cross linking is the suggesting hypothesis. Nevertheless, these findings were not repeated in other studies.[62]

Endothelial damage

The major concern in applying UVA for corneal cross linkage was endothelial damage. UVA is potentially dangerous for endothelial cells and these cells are incapable of regeneration and offence at any level is irreversible. Ultraviolet A induces apoptosis in keratinocytes. This process continues even after the surgery and peaks 24 hours then after. In corneal diameter <400 microns, apoptotic changes were seen even in the endothelial layer. The depth of the injury depends on corneal diameter and UVA density of energy. With the current protocol, crosslink changes occur maximum 350 micron from the surface and the max energy density is 0.18 mW/cm2, which is far less than the threshold for endothelial damage (0.35 mW/cm2).[50] All researchers who demonstrated adherence to the standard protocol reported no injury to the endothelium. Keratinocytes start regeneration 2–3 weeks postoperative and become compete in 6 months.[63]

Conclusion

Keratoconus is one of the leading causes of cornea transplant. Therapies based on the spectacles and contact lenses do not hinder the progression of the disease. Surgeries and corneal transplantation though preserved as the first choice for the severe variants of the disease do have risks like rejection of the transplanted cornea. Moreover surgical results are not always satisfying. Corneal crosslink is a noble strategy based on the underlying pathology of the disease. Experimental and clinical researchers have demonstrated the efficacy of this approach. Side effects like endothelial damage that were the major concerns have not been reported under the standard method.
  60 in total

1.  Increased resistance of crosslinked cornea against enzymatic digestion.

Authors:  Eberhard Spoerl; Gregor Wollensak; Theo Seiler
Journal:  Curr Eye Res       Date:  2004-07       Impact factor: 2.424

Review 2.  Keratoconus: a review.

Authors:  Miguel Romero-Jiménez; Jacinto Santodomingo-Rubido; James S Wolffsohn
Journal:  Cont Lens Anterior Eye       Date:  2010-08       Impact factor: 3.077

3.  The cascade hypothesis of keratoconus.

Authors:  M Cristina Kenney; Donald J Brown
Journal:  Cont Lens Anterior Eye       Date:  2003-09       Impact factor: 3.077

4.  The Dundee University Scottish Keratoconus study: demographics, corneal signs, associated diseases, and eye rubbing.

Authors:  K H Weed; C J MacEwen; T Giles; J Low; C N J McGhee
Journal:  Eye (Lond)       Date:  2007-01-19       Impact factor: 3.775

5.  Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A.

Authors:  Matthias Pollhammer; Claus Cursiefen
Journal:  J Cataract Refract Surg       Date:  2009-03       Impact factor: 3.351

6.  Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results.

Authors:  Frederik Raiskup-Wolf; Anne Hoyer; Eberhard Spoerl; Lutz E Pillunat
Journal:  J Cataract Refract Surg       Date:  2008-05       Impact factor: 3.351

7.  Collagen fiber diameter in the rabbit cornea after collagen crosslinking by riboflavin/UVA.

Authors:  Gregor Wollensak; Michaela Wilsch; Eberhard Spoerl; Theo Seiler
Journal:  Cornea       Date:  2004-07       Impact factor: 2.651

8.  Contralateral eye study of corneal collagen cross-linking with riboflavin and UVA irradiation in patients with keratoconus.

Authors:  Efekan Coskunseven; Mirko R Jankov; Farhad Hafezi
Journal:  J Refract Surg       Date:  2009-04       Impact factor: 3.573

9.  Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking.

Authors:  Gregor Wollensak; Eberhard Spoerl; Theo Seiler
Journal:  J Cataract Refract Surg       Date:  2003-09       Impact factor: 3.351

10.  Congenital Leber amaurosis, keratoconus, and mental retardation in familial juvenile nephronophtisis.

Authors:  V Godel; M Blumenthal; A Iaina
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1978 Mar-Apr       Impact factor: 1.402

View more
  6 in total

1.  Is keratoconus more severe in pediatric population?

Authors:  Mohammad Naderan; Mohammad Taher Rajabi; Parviz Zarrinbakhsh; Mahgol Farjadnia
Journal:  Int Ophthalmol       Date:  2016-10-25       Impact factor: 2.031

Review 2.  The Proteins of Keratoconus: a Literature Review Exploring Their Contribution to the Pathophysiology of the Disease.

Authors:  Eleftherios Loukovitis; Nikolaos Kozeis; Zisis Gatzioufas; Athina Kozei; Eleni Tsotridou; Maria Stoila; Spyros Koronis; Konstantinos Sfakianakis; Paris Tranos; Miltiadis Balidis; Zacharias Zachariadis; Dimitrios G Mikropoulos; George Anogeianakis; Andreas Katsanos; Anastasios G Konstas
Journal:  Adv Ther       Date:  2019-07-30       Impact factor: 3.845

3.  Alterations in Corneal Biomechanical and Topographic Features After Accelerated Crosslinking: 1-Year Results.

Authors:  Ahmet Kirgiz; Sevil Karaman Erdur; Kubra Serefoglu Cabuk; Kursat Atalay; Senay Asik Nacaroglu
Journal:  Beyoglu Eye J       Date:  2019-08-08

4.  Higher-order aberration 4 years after corneal collagen cross-linking.

Authors:  Mohammad Naderan; Ali Jahanrad
Journal:  Indian J Ophthalmol       Date:  2017-09       Impact factor: 1.848

Review 5.  Patient selection for corneal collagen cross-linking: an updated review.

Authors:  Virgilio Galvis; Alejandro Tello; Alvaro I Ortiz; Luis C Escaf
Journal:  Clin Ophthalmol       Date:  2017-04-07

6.  Human in vitro Model Reveals the Effects of Collagen Cross-linking on Keratoconus Pathogenesis.

Authors:  Rabab Sharif; Jesper Hjortdal; Henrik Sejersen; Garett Frank; Dimitrios Karamichos
Journal:  Sci Rep       Date:  2017-10-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.